Related Experiment Video
Updated: Aug 20, 2025
08:23
Xenograft Skin Model to Manipulate Human Immune Responses In Vivo
Published on: June 29, 2022
3.2K
Cutaneous Oncology in the Immunosuppressed
Leo L Wang1, Stephanie K Lin2, Carolyn M Stull1
1Department of Dermatology, Perelman Center for Advanced Medicine, University of Pennsylvania, 1st Floor South Pavilion, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Dermatologic Clinics
|November 21, 2022
Summary
Immunocompromised patients face higher risks of skin cancer, including keratinocyte carcinoma and melanoma. This review covers managing these malignancies in conditions like acquired immunodeficiencies and after organ transplantation.
Area of Science:
- Dermatology
- Oncology
- Immunology
Background:
- Patients with immunosuppressive conditions exhibit a higher incidence and severity of cutaneous malignancies.
- Skin cancers are a significant concern in individuals with lymphoproliferative disorders, acquired immunodeficiencies, and organ transplant recipients.
Purpose of the Study:
- To review the management of various skin cancers in immunocompromised patients.
- To discuss specific malignancies including keratinocyte carcinoma, melanoma, Merkel cell carcinoma, and Kaposi sarcoma.
- To highlight recent advancements in the field.
Main Methods:
- Literature review focusing on skin cancer management in immunocompromised populations.
- Analysis of current therapeutic strategies and risk factor identification.
- Examination of advances in immunosuppression safety for organ transplant recipients.
Main Results:
- Management protocols for keratinocyte carcinoma, melanoma, Merkel cell carcinoma, and Kaposi sarcoma in specific immunosuppressive states were reviewed.
- The article emphasizes the importance of early risk factor identification.
- Advances in immunosuppression and targeted therapies are showing positive impacts.
Conclusions:
- Improved outcomes for skin cancer in immunocompromised populations are achievable.
- Advances in immunosuppression safety and targeted therapies are crucial.
- Continued research and vigilant management are essential for this patient group.
Related Concept Videos
01:30Skin Cancer
4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
01:27Tumor Immunotherapy
631
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
631
01:23Skin Diseases and Disorders
4.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.0K
01:25Immunodeficiency Diseases
1.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.1K
01:27Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K